3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Pancreatic Neoplasms
3
Neuroendocrine Tumors
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Liver Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Carcinoid Tumor
2
Uveal Melanoma
1
Thyroid Neoplasms
1
Sarcoma, Synovial
1
Prolactinoma
1
Prolactin-Producing Pituitary Tumor
1
Primary Inoperable Thymoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pituitary Neoplasms
1
Peritoneal Neoplasms
1
Pancreatic Fistula
1
Neoplasms
1
Nelson Syndrome
1
Myelodysplastic Syndromes
1
Meningioma
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Insulinoma
1
Hypoglycemia
1
Hyperinsulinism
1
Hematologic Neoplasms
1
Interventions
Vincristine
4
Etoposide
4
Doxorubicin
4
Cyclophosphamide
4
Thiotepa
3
Temozolomide
3
Ifosfamide
3
Filgrastim
3
Cisplatin
3
fludarabine phosphate
2
Radiotherapy
2
Melphalan
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Granulocyte Colony-Stimulating Factor
2
Cytoreduction Surgical Procedures
2
Brachytherapy
2
thymoglobulin
1
temsirolimus
1
sodium thiosulfate
1
prexasertib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
pazopanib
1
pasireotide
1
fludarabine
1
Zoledronic Acid
1
X-Rays
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Desmoplastic Small Round Cell Tumor
×
pasireotide
×
Clear all
NCT06456359
2025-01-13
PAMSARC
University Hospital Heidelberg
Phase 2
Recruiting
28 enrolled